PLASMA PCSK9 AND CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES

被引：0
|
作者：
El Khoury, Petra [1 ,2 ]
Roussel, Ronan [3 ,4 ,5 ]
Fumeron, Frederic [4 ,5 ]
Velho, Gilberto [5 ]
Jacob, Marie-Paule [1 ,4 ]
Steg, Gabriel [1 ,4 ,6 ,7 ]
Potier, L. [3 ,4 ,5 ]
Ghaleb, Youmna [1 ,2 ,4 ]
Elbitar, Sandy [1 ,2 ,4 ]
Abifadel, Marianne [1 ,2 ]
Boileau, Catherine [1 ,4 ,8 ]
Marre, Michel [3 ,4 ,5 ]
Varret, Mathilde [1 ,4 ]
Hansel, Boris [3 ,4 ,5 ]
机构：
[1] INSERM, U1148, Paris, France
[2] St Joseph Univ, Beruth, Lebanon
[3] CHU Bichat, Aphp, Dept Nutr, Paris, France
[4] Denis Diderot Univ Paris 7, Paris, France
[5] INSERM, U1138, Paris, France
[6] CHU Bichat, Aphp, Dept Cardiol, Paris, France
[7] Imperial Coll, NHLI, Royal Brompton Hosp, London, England
[8] CHU Bichat, Aphp, Dept Genet, Paris, France
来源：
ATHEROSCLEROSIS | 2017年 / 263卷
关键词：
D O I：
10.1016/j.atherosclerosis.2017.06.263
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAG142
引用
收藏
页码：E81 / E81
页数：1
相关论文
共 50 条
  • [31] PCSK9 inhibition reduces cardiovascular events in high-risk patients
    Karina Huynh
    Nature Reviews Cardiology, 2017, 14 : 251 - 251
  • [32] PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention
    Paciullo, Francesco
    Momi, Stefania
    Gresele, Paolo
    THROMBOSIS AND HAEMOSTASIS, 2019, 119 (03) : 359 - 367
  • [33] Letter to editor regarding effect of empagliflozin on plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with type 2 diabetes
    Seetharaman, Rajmohan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 191
  • [34] PCSK9 inhibitors and reduction in cardiovascular events: Current evidence and future perspectives
    Nicholls, Stephen J.
    KARDIOLOGIA POLSKA, 2023, 81 (02) : 115 - 122
  • [35] PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
    Schmidt, Amand F.
    Swerdlow, Daniel I.
    Holmes, Michael V.
    Patel, Riyaz S.
    Fairhurst-Hunter, Zammy
    Lyall, Donald M.
    Hartwig, Fernando Pires
    Horta, Bernardo Lessa
    Hypponen, Elina
    Power, Christine
    Moldovan, Max
    van Iperen, Erik
    Hovingh, G. Kees
    Demuth, Ilja
    Norman, Kristina
    Steinhagen-Thiessen, Elisabeth
    Demuth, Juri
    Bertram, Lars
    Liu, Tian
    Coassin, Stefan
    Willeit, Johann
    Kiechl, Stefan
    Willeit, Karin
    Mason, Dan
    Wright, John
    Morris, Richard
    Wanamethee, Goya
    Whincup, Peter
    Ben-Shlomo, Yoav
    McLachlan, Stela
    Price, Jackie F.
    Kivimaki, Mika
    Welch, Catherine
    Sanchez-Galvez, Adelaida
    Marques-Vidal, Pedro
    Nicolaides, Andrew
    Panayiotou, Andrie G.
    Onland-Moret, N. Charlotte
    van der Schouw, Yvonne T.
    Matullo, Giuseppe
    Fiorito, Giovanni
    Guarrera, Simonetta
    Sacerdote, Carlotta
    Wareham, Nicholas J.
    Langenberg, Claudia
    Scott, Robert
    Luan, Jian'an
    Bobak, Martin
    Malyutina, Sofi A.
    Pajak, Andrzej
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (02): : 97 - 105
  • [36] Circulating PCSK9 is associated with pentraxin 3 concentration in patients with type 2 diabetes
    Walus, M.
    Kapusta, M.
    Trojak, A.
    Miarka, P.
    Idzior-Walus, B.
    Malecki, M. T.
    DIABETOLOGIA, 2017, 60 : S569 - S570
  • [37] Association of genetic polymorphisms of PCSK9 with type 2 diabetes in Uygur Chinese population
    Meng-Meng Wang
    Chen-Fei Lu
    Shi-qi Yan
    Bao-Zhu Wang
    Gulinazi Yesitayi
    Yong-Liang Tian
    Yi-Tong Xiang-Ma
    BMC Cardiovascular Disorders, 22
  • [38] Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study
    Ruscica, Massimiliano
    Macchi, Chiara
    Giuliani, Angelica
    Rizzuto, Alessandra Stefania
    Ramini, Deborah
    Sbriscia, Matilde
    Carugo, Stefano
    Bonfigli, Anna Rita
    Corsini, Alberto
    Olivieri, Fabiola
    Sabbatinelli, Jacopo
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [39] Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women
    Levenson, Amy E.
    Shah, Amy S.
    Khoury, Philip R.
    Kimball, Thomas R.
    Urbina, Elaine M.
    de Ferranti, Sarah D.
    Maahs, David M.
    Dolan, Lawrence M.
    Wadwa, R. Paul
    Biddinger, Sudha B.
    PEDIATRIC DIABETES, 2017, 18 (08) : 755 - 760
  • [40] Association of genetic polymorphisms of PCSK9 with type 2 diabetes in Uygur Chinese population
    Wang, Meng-Meng
    Lu, Chen-Fei
    Yan, Shi-Qi
    Wang, Bao-Zhu
    Yesitayi, Gulinazi
    Tian, Yong-Liang
    Xiang-Ma
    Ma, Yi-Tong
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
12345